Combretastatin A-4

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ether doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514721, 568631, 568646, A61K 31075

Patent

active

049962370

ABSTRACT:
The African tree Combretum caffrum (Combretaceae) has been found to contain an agent which is a powerful inhibitor of tubulin polymerization (IC50 2-3 .mu.M), the growth of murine lymphocytic leukemia (L1210 and P388 with ED50 <0.003 mg/ml and human colon cancer cell lines (e.g. VoLo with ED50 <0.01 .mu.g/ml). This agent is herein denominated "combretastatin A-4". The structure assigned by spectral techniques was confirmed by synthesis.

REFERENCES:
patent: 4094994 (1978-06-01), Schonenberger et al.
Venditti et al., Lloydia, 30, 332-348 (1967).
Kettenes-Van den Bosch, et al., Chem. Abs., 89, 160092x (1978).
Majumder et al., Chem. Abs., 102, 92950k (1985).
Crombie et al., J. Chem. Soc. Perkin Trans. I, "Dihydrostilbenes of Cannabis. Synthesis of Canniprene", pp. 1467-1475 (1982).
Pettit, et al., Chem. Abs., 110, 4696u (1989).
Pettit, et al., Chem. Abs., 109, 122076u (1988).
Pettit, et al., Chem. Abs., 108, 72037p (1988).
Pettit, et al., Chem. Abs., 107, 236347x (1987).
Pettit, et al., Chem. Abs., 107, 112617r (1987).
Pettit, et al., Chem. Abs., 103, 160277u (1985).
Pettit, et al., Chem. Abs., 97, 107051x (1982).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Combretastatin A-4 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combretastatin A-4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combretastatin A-4 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-294235

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.